ReviewCureus2023

Pathologic Complete Response Achieved in Early-Stage HER2-Positive Breast Cancer After Neoadjuvant Therapy With Trastuzumab and Chemotherapy vs. Trastuzumab, Chemotherapy, and Pertuzumab: A Systematic Review and Meta-Analysis of Clinical Trials.

Faizan Fazal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.